eJIFCC: www.ifcc.

org/ejifcc

How to Cite this article: Critical Limits of Laboratory Results for Urgent Clinician Notification, eJIFCC vol 14 no 1: http://www.ifcc.org/
ejifcc/vol14no1/140103200303n.htm

Critical limits of laboratory

results for urgent clinician
notification
Professor Dr Lothar Thomas
Kirschbaumweg 8, 60489 Frankfurt
E-mail: [email protected]

The laboratory should not report a criti-cal result to the

treating physician until it has been confirmed by a second
deter-mination in the same sample.
The laboratory test value should be ascertained by a
competent member of the laboratory (laboratory doctor,
clinical chemist, senior medical laboratory tech-nician)
who should discuss the result with the treating physician.

Critical limits of laboratory results need urgent notification

to the clinician because they are an indicator of a critical
or even life-threatening condition of the patient.

This is because influences and interfer-ence factors in the

preanalytical phase, e.g. sample collection for glucose
measurement using a venous catheter that had been used
for glucose infusion, are not infrequently the cause of
seemingly critical values. Such cases are usually clarified by
the testing of another, properly collected sample.

The publications about this topic are mainly from the

1970s. Since then, many laboratory methods have been
improved, new parameters have been added, and there
have also been changes in the evaluation and treatment of
diseases.

The specified parameters and limits are taken partly from

[1]. The others are based on 25 years experience as a
doctor for laboratory medicine working in a hospital.
References:

Against this background and at the request of the American Medical Association, J.G. Kost [1] conducted a survey
on critical pa-rameters in the USA in 1990 and Howanitz
et al. [2] in 2002. The spectrum of critical pa-rameters
reported in these publications does not meet the requirements of laboratory medicine in every respect.
I have therefore put together a new list of qualitative and
quantitative parameters. If you think there are parameters
that should perhaps be added or deleted, limits, which
need changing, or notes that need to be amended, your
suggestions would be most welcome.

Kost, GJ. Critical limits for urgent clinician notification at

US medical centers. JAMA 1990; 263: 704-7
Howanitz PJ, Steindel SJ, Heard NV. Laboratory critical
values, policies and procedures. A College of Ameri-can
Pathologists Q-probes study in 623 institutions. Arch
Pathol Lab Med 2002; 126: 663-9.

Quantitative laboratory test results for the blood and

extravascular body fluids are indicators, for example, of
organic disease, metabolic disorders, diseases of the
haematopoietic system, disturbances of haemostasis,
abnormalities of the endocrine system, activation or
insufficiency of the immune system, inflammation,
infections, and autoimmune processes.
High detection sensitivity, a wide measurement range, and
good to acceptable precision and accuracy, allow blood
parameters to be determined in concentration ranges,
which indicate that the patient is in acute danger or even a
danger to others. The laboratory must report such results
to the treating physi-cian immediately. For this to happen,
there must be an agreement between the treating physician
and the laboratory as to what constitutes a critical result
that needs to be reported to him. The parameters chosen
and the critical limits depend essentially on the disease
prevalence expected in the clinic or practice.

Vol 14 No 1

eJIFCC: www.ifcc.org/ejifcc

Table 1: Adult and paediatric limits of laboratory results which, after confirmation
through repeat measurement in the same sample, need urgent notification of the
physician

Parameter

Value

Note

Activated
partial
thromboplastin
time (APTT)

75 sec

Deficiency or inactivity of factor VIII, IX, XI, or

XII, with risk of haemorrhage. In persons
receiving heparin therapy there is a risk of
haemorrhage if the APTT is more than 2.5 times
higher than the upper reference limit.

Aminotransferases

> 1000 U/l

Notification depends on the patient population of

the clinic or practice in question.

Ammonia

> 100 mg/dl (59

mmol/l)

Risk of hepatic encephalopathy. Comatose states

do not usually occur unless levels exceed 300
mg/dl (176 mmol/l).

Anion gap

> 20 mmol/l

Indicative of ketoacidosis or lactacidosis, uraemia,

alcohol consumption, salicylate intoxication,
poisoning from methanol or ethylene glycol.

Inorganic
phosphate

< 1.0 mg/dl

(0.32mmol/l)

Muscle weakness, muscle pain, central-nervous

symptoms such as disorientation, confusion,
convulsions, coma, respiratory insufficiency with
metabolic acidosis.

> 9.0 mg/dl (2.9

mmol/l)

Occurs in acute tumour lysis syndrome and in

terminal renal failure.
Antithrombin
(AT)

< 50%

There is substantial inhibitor deficiency, which in

those with elevated procoagulant activity poses a
high risk of thromboembolic complications.

Ethanol

> 3.5 g/l (76

mmol/l)

Blood alcohol concentrations of 3-4 g/l can be

fatal, even in those who are not simultaneously
using medicinal products.

> 3.5 %
Bilirubin

> 15 mg/dl (257

mmol/l)

Hepatobiliary disease caused mainly by

hepatotropic viruses and thus of infectious origin
with risk of contagion.

Vol 14 No 1

eJIFCC: www.ifcc.org/ejifcc

Parameter
Chloride

Value

Note

< 75 mmol/l

Indicative of considerable metabolic alkalosis.

>125 mmol/l

Indicative of massive primary metabolic acidosis

or pseudohyperchloraemia in the case of bromide
intoxication.

Creatinine

> 7.4 mg/dl (654

mmol/l)

Acute renal failure, e.g. in multiple organ failure

or sepsis.

Creatine kinase

> 1000 U/l

Notification depends on the patient population of

the clinic or practice in question.

D-dimers

Positive

In disseminated intravascular coagulation (DIC),

detection of D-dimers is indicative of phase II
(decompensated activation of the haemostasis
system) or phase III (full-blown DIC).

Digoxin

> 2.0 mg/l (2.56

nmol/l)
> 40 mg/l (52
nmol/l)

Non-cardiac symptoms such as tiredness, muscle

weakness, nausea, vomiting, lethargy, and
headache and cardiac symptoms such as sinus
arrhythmia, bradycardia, and various degrees of
AV block.

Fibrinogen

< 0.8 g/l

Risk of haemorrhage.

Fibrin
monomers

Positive

Indicative of consumption coagulopathy in

disseminated intravascular coagulation, sepsis,
shock, multiple injury, acute pancreatitis, and
obstetric complications.

Glucose

< 45 mg/dl (2.5

mmol/l)

Neuroglycopenic symptoms, which can range

from impairment of cognitive functions to loss of
consciousness.

Digitoxin

> 500mg/dl
(27.8 mmol/l)

Diabetic coma due to insulin deficiency.

Development of osmotic diuresis with severe
exsiccosis and diabetic ketoacidosis (bhydroxybutyrate > 5 mmol/l, standard
bicarbonate < 10 mmol/l).

Vol 14 No 1

eJIFCC: www.ifcc.org/ejifcc

Parameter
Haemoglobin

Value

Note

< 6.6 g/dl

Supply of oxygen to the myocardium inadequate.

> 19.9 g/dl

Corresponds to haematocrit of 61% and leads to

hyperviscosity syndrome.

Lactate

> 45 mg/dl (5.0

mmol/l)

Indicator of type A hyperlactataemia, which is

caused by an inadequate supply of oxygen to the
tissue. Pyruvate is no longer metabolised
oxidatively, but reductively.

Lactate
dehydrogenase

> 1000 U/l

Notification depends on the patient population of

the clinic or practice in question.

Leukocyte
count

< 2000/ml

High risk of infection if the granulocyte count is <

500/ml.

> 50,000/ml
Indicative of leukemoid reaction, e.g. in sepsis, or
of leukemia.
Lipase

> 700 U/l

Indicative of acute pancreatitis.

Magnesium

< 1.0 mg/dl (0.41

mmol/l)

Characteristic symptoms are paresthesias, cramp,

irritability, and athetoid tetany. The patient often
shows cardiac arrhythmia in conjunction with
hypokalemia; arrhythmia is intensified by
digitalis.

> 4.9 mg/dl (5.0

mmol/l)

Reduction of neuromuscular impulse

transmission, resulting in sedation, hypoventilation with respiratory acidosis, muscle
weakness, and reduced tendon reflexes.
Myoglobin

> 110 mg/l

Myocardial infarction should be suspected in

patients with angina pectoris.

Vol 14 No 1

eJIFCC: www.ifcc.org/ejifcc

Parameter
Osmolality

Value
< 240 mOsm/kg
H2O
> 330 mOsm/kg
H2O

Osmolar gap

pCO2

> 10 mOsm/kg
H2O

< 19 mm Hg (2.5
kPa)

Note
Cellular oedema with an increase in cell volume
and development of neurological-psychiatric
symptoms.
Cellular water loss and intracellular increase in
osmotically active substances, which do not
permeate the cell membrane. Result: central
symptoms and coma.
Indicative of intoxication from non-electrolytes,
which increase plasma osmolality, such as
ethanol, methanol, ethylene glycol, isopropanol,
and dichloromethane.

Hyperventilation
Hypoventilation

> 67 mm Hg (8.9
kPa)
pH

< 7.2
> 7.6

pO2

< 43 mm Hg (5.7
kPa)

Such pH values are characteristic of severely

decompensated acidosis or alkalosis. Values <
7.20 and > 7.60 are life-threatening.
Such values correspond to a haemoglobin oxygen
saturation of less than 80% and are to be regarded
as life-threatening.

Vol 14 No 1

eJIFCC: www.ifcc.org/ejifcc

Parameter
T4, free

Value
> 35 ng/l (45
pmol/l)

T3, total
> 30 mg/l (46
nmol/l)

Note
Indicative of thyrotoxicosis, a condition
detectable clinically and in laboratory tests; the
tissues are exposed to too high a thyroid
hormone concentration and react to this. Possible
causes are: Graves disease, trophoblastic tumour,
hyperfunctional adenoma, toxic nodular goitre,
and, in rare instances, overproduction of TSH.

Thromboplastin
time (TT)

> 27 sec (approx.

50%)

Decrease in the vitamin K-dependent factors II,

VII, and X or in factor V. Since all these factors
are synthesized in the liver, a decrease in the TT
to values below the specified level indicates a
considerable disturbance of synthesis. In persons
receiving coumarin therapy, there is a risk of
haemorrhage if the TT is < 15% which
corresponds roughly to an INR of > 4.

Platelet count

< 20,000/ml

Risk of haemorrhage. Exclude EDTA-induced

thrombocytopenia.

> 1 million/ml
Risk of thrombosis.
Troponin

> 0.1 mg/l

Indicative of myocardial infarct or unstable

angina pectoris.

Uric acid

> 13 mg/dl (773

mmol/l)

Acute urate nephropathy with tubular blockade

and renal failure. The uric acid/creatinine ratio in
spontaneous urine in such cases is > 1.0 (mg/mg).

Urea

> 214 mg/dl (35.6

mmol/l)

Indicative of acute renal failure; unlike pre-renal

and post-renal kidney failure, no
disproportionate increase in urea compared to
creatinine in serum.

BUN
> 100 mg/dl (35.6
mmol/l)

Vol 14 No 1

eJIFCC: www.ifcc.org/ejifcc

Table 2: Critical limits of qualitative laboratory results which must be reported to

the treating physician immediately
Cerebrospinal fluid

Increased cell count

Leukocytosis, tumour cells
Glucose lower than in serum
Lactate > 20 mg/dl (2.2 mmol/l)
Detection of pathogens in Gram stain or agglutination test

Urine Strongly positive test strip reaction for glucose and acetone

Red cell casts or > 50% dysmorphic erythrocytes

Severe haemoglobinuria (no erythrocytes on microscopic examination)
Detection of drugs
Differential blood count Leukemoid reaction

Suspected leukemia

Suspected aplastic crisis

Sickle cells
Malarial parasites

Microbiology Detection of pathogens in Gram staining of blood culture or of exudates and

transudates of body cavities

Antigenic detection of pathogens with rapid tests such as latex agglutination, immunofluorescence, or immunoassay, e.g. group B
streptococci, legionella, Pneumocystis carinii, Cryptococcus, hepatitis B

Detection of acid-fast bacilli or detection of M. tuberculosis after amplification (PCR)

Cultural detection of salmonellae, shigella, Campylobacter, C. difficile, C. perfringens, N. gonorrhoeae, B. pertussis, N.
menin-gitidis, C. diphtheriae, and pathogenic fungi such as Aspergillus, Blastomyces, Coccidioides, Histoplasma, and Cryptococcus

Detection of HIV antibodies

Vol 14 No 1

eJIFCC: www.ifcc.org/ejifcc
Table 3: Neonatal quantitative limits of laboratory results which, after confirmation
through repeat measurement in the same sample, need urgent notification by the
physician.

Parameter

Value

Note

Bilirubin

> 14 mg/dl (239

mmol/l)

On first day of life, e.g. in hemolytic disease of the

newborn; risk of kernicterus.

C-reactive
protein

> 5mg/l

Indicative of neonatal sepsis.

Glucose

< 30 mg/dl (1.7

mmol/l)

Hypoglycemia, caused, for example, by a congenital

metabolic disorder or hyperinsulinism due to
maternal diabetes mellitus. Glucose concentrations <
25 mg/dl (1.3 mmol/l) should be treated by parenteral
administration of glucose.
Urgent clarification of pathogenicity required.

> 325 mg/dl (18

mmol/l)
Hematocrit

< 33% (L/L)

>71% (L/L)
Hemoglobin

< 8.5 g/dl

> 23 g/dl

Indicative of marked anemia with an inadequate

supply of oxygen to tissue.
Hyperviscosity of the blood with increased
circulatory resistance.
Risk of multiorgan failure, especially if the patient
has a combination of ischemia and hypoxia.
Abnormal flow kinetics (hyperviscosity) with
increased circulatory resistance and an increased
load on the heart.

Igm

> 20 mg/dl

A cord blood IgM concentration above the limit can

be linked to an intrauterine infection.

Potassium

< 2.6 mmol/l

Occurrence of neuromuscular symptoms with

hyporeflexia and paralysis of the respiratory muscles.

7.7 mmol/l

Leukocyte count

< 5,000/ml

Clinical consequences are heart-rhythm disturbances,

weakness of the skeletal muscles, and respiratory
paralysis.

Values below and above these limits can be

indicative of neonatal sepsis.

> 25,000/ml
pO2

< 37 mm Hg (4.9

Drop in hemoglobin oxygen saturation to below 85%.

Vol 14 No 1